Urgent Care for aphthous ulcers, cold sores and dry sockets
Orafate™ (polymerized and cross-linked sucralfate) is associated with rapid healing and treatment of canker sores (aphthous ulcers), cold sores (herpes labialis) and dry sockets (alveolar osteitis)
Orafate™ is a new post-surgical treatment for oral wounds
Orafate™ is FDA-cleared and addresses the unmet dental needs caused by mild to moderate gingivitis, dental procedure wounds, post-op surgical wounds and severe periodontitis
Orafate™ accelerates the healing while reducing the pain
Orafate™ can be used by ENT surgeons to effectively accelerate the healing of post-op surgical wounds of tonsillectomies and uvuloplasty
Urgent Care for aphthous ulcers, cold sores and dry sockets
Orafate™ (polymerized and cross-linked sucralfate) is associated with rapid healing and treatment of canker sores (aphthous ulcers), cold sores (herpes labialis) and dry sockets (alveolar osteitis)
In-Office Orafate Procedures andOut-of-Office Prescription
Orafate™, a new FDA prescription
oral wound medical device,
containing enhanced potency
sucralfate, is being launched for
use as a reimbursable in-office
procedure, following all
cleanings and all extractions,
reimbursable under ADA procedure
code D9630. [Learn More]
Orafate™ is a patented high potency
reformulation of sucralfate used for
the management of oral wounds and
inflammation. The clinical effects of
Orafate™ is conveyed solely
through its physical contact with the
inflamed, injured or ulcerated lining.
Orafate™ should be used 3 times daily
for the 1st day then twice daily for
1 week or as directed by the dentist
or healthcare provider. [Read more]
